Literature DB >> 18841223

Surgical outcomes in women with ovarian cancer.

Laurie M Elit1, Susan J Bondy, Lawrence P Paszat, Eric J Holowaty, Gillian M Thomas, Therese A Stukel, Mark N Levine.   

Abstract

OBJECTIVE: We sought to assess whether the specialty of the surgeon or the hospital involved in the initial management of women with ovarian cancer determined the likelihood of unnecessary repeated abdominal surgery and long-term patient survival.
METHODS: We conducted a population-based study involving women in Ontario, Canada, who had epithelial ovarian cancer treated initially with abdominal surgery between January 1996 and December 1998. We documented incident surgical cases using hospital contact data and the Ontario Cancer Registry. We obtained data on patient characteristics, clinical findings, surgical techniques and perioperative care from electronic administrative data records and patient charts. We performed regression analyses to assess the influence of surgeon and hospital specialization and of case volumes on the likelihood of repeat surgery and survival. We controlled for stage of disease and other factors associated with these outcomes. We also examined the relation between the adequacy of surgery and adjuvant chemotherapy with survival.
RESULTS: A total of 1341 women met our inclusion criteria. Our analysis showed that repeat surgery was associated with the surgeon's discipline, younger patient age, well-differentiated tumours and early stage of disease. However, survival was not associated with the surgeon's discipline; rather, it was associated with advanced patient age, increasing comorbidities, advanced stage of disease, poorly differentiated tumours, urgent surgery and adjuvant chemotherapy. We observed a trend between inadequate surgery and a decreased likelihood of survival.
CONCLUSION: Further study is needed to understand patterns of repeat surgery for ovarian cancer. Improved quality of operative reporting is required to classify surgical adequacy.

Entities:  

Mesh:

Year:  2008        PMID: 18841223      PMCID: PMC2556534     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  21 in total

1.  The impact of specialist training for surgery in ovarian cancer.

Authors:  E. Junor
Journal:  Int J Gynecol Cancer       Date:  2000-01       Impact factor: 3.437

2.  Outcomes in surgery for ovarian cancer.

Authors:  L Elit; S J Bondy; L Paszat; R Przybysz; M Levine
Journal:  Gynecol Oncol       Date:  2002-12       Impact factor: 5.482

3.  Ovarian cancer staging: does it require a gynecologic oncologist?

Authors:  A R Mayer; S K Chambers; E Graves; C Holm; P C Tseng; B E Nelson; P E Schwartz
Journal:  Gynecol Oncol       Date:  1992-11       Impact factor: 5.482

4.  Systematic surgical staging: stage I ovarian cancer.

Authors:  M S Piver
Journal:  J Clin Oncol       Date:  1997-02       Impact factor: 44.544

5.  Specialized surgery in ovarian cancer.

Authors:  M S Piver
Journal:  Eur J Cancer Clin Oncol       Date:  1987-02

6.  Use of cancer registry data to evaluate the treatment of ovarian cancer on a hospital basis.

Authors:  D J Hole; C R Gillis
Journal:  Health Rep       Date:  1993       Impact factor: 4.796

7.  Development of ovarian cancer surgery quality indicators using a modified Delphi approach.

Authors:  Anna R Gagliardi; Michael Fung Kee Fung; Bernard Langer; Hartley Stern; Adalsteinn D Brown
Journal:  Gynecol Oncol       Date:  2005-05       Impact factor: 5.482

Review 8.  Who should operate on patients with ovarian cancer? An evidence-based review.

Authors:  Kurt Christopher Giede; Katharina Kieser; Jason Dodge; Barry Rosen
Journal:  Gynecol Oncol       Date:  2005-08-29       Impact factor: 5.482

9.  Reasons for incomplete surgical staging in early ovarian carcinoma.

Authors:  J B Trimbos; J A Schueler; M van Lent; J Hermans; G J Fleuren
Journal:  Gynecol Oncol       Date:  1990-06       Impact factor: 5.482

10.  Staging laparotomy in early ovarian cancer.

Authors:  R C Young; D G Decker; J T Wharton; M S Piver; W F Sindelar; B K Edwards; J P Smith
Journal:  JAMA       Date:  1983-12-09       Impact factor: 56.272

View more
  7 in total

1.  S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.

Authors:  U Wagner; P Harter; F Hilpert; S Mahner; A Reuß; A du Bois; E Petru; W Meier; P Ortner; K König; K Lindel; D Grab; P Piso; O Ortmann; I Runnebaum; J Pfisterer; D Lüftner; N Frickhofen; F Grünwald; B O Maier; J Diebold; S Hauptmann; F Kommoss; G Emons; B Radeleff; M Gebhardt; N Arnold; G Calaminus; I Weisse; J Weis; J Sehouli; D Fink; A Burges; A Hasenburg; C Eggert
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

Review 2.  Centralisation of services for gynaecological cancer.

Authors:  Yin Ling Woo; Maria Kyrgiou; Andrew Bryant; Thomas Everett; Heather O Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

Review 3.  The optimal organization of gynecologic oncology services: a systematic review.

Authors:  M Fung-Kee-Fung; E B Kennedy; J Biagi; T Colgan; D D'Souza; L M Elit; A Hunter; J Irish; R McLeod; B Rosen
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

4.  Evaluation of prevalent and incident ovarian cancer co-morbidity.

Authors:  K Stålberg; T Svensson; F Granath; H Kieler; B Tholander; S Lönn
Journal:  Br J Cancer       Date:  2012-05-01       Impact factor: 7.640

5.  Comorbidity and survival among women with ovarian cancer: evidence from prospective studies.

Authors:  Yi-Sheng Jiao; Ting-Ting Gong; Yong-Lai Wang; Qi-Jun Wu
Journal:  Sci Rep       Date:  2015-06-29       Impact factor: 4.379

6.  Impact of Age, Comorbidity, and FIGO Stage on Treatment Choice and Mortality in Older Danish Patients with Gynecological Cancer: A Retrospective Register-Based Cohort Study.

Authors:  Sambavy Nadaraja; Trine Lembrecht Jørgensen; Lars-Erik Matzen; Jørn Herrstedt
Journal:  Drugs Real World Outcomes       Date:  2018-12

Review 7.  ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors.

Authors:  Dirk Timmerman; François Planchamp; Tom Bourne; Chiara Landolfo; Andreas du Bois; Luis Chiva; David Cibula; Nicole Concin; Daniela Fischerova; Wouter Froyman; Guillermo Gallardo Madueño; Birthe Lemley; Annika Loft; Liliana Mereu; Philippe Morice; Denis Querleu; Antonia Carla Testa; Ignace Vergote; Vincent Vandecaveye; Giovanni Scambia; Christina Fotopoulou
Journal:  Int J Gynecol Cancer       Date:  2021-06-10       Impact factor: 3.437

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.